Trial Profile
A Multicenter, Open-label, Single-dose Study to Evaluate the Pharmacokinetics of Valsartan in Japanese Pediatric Patients 6 to 14 Years of Age.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs Valsartan (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Novartis Pharmaceuticals
- 07 May 2012 Actual patient number 12 added as reported by ClinicalTrials.gov.
- 07 May 2012 Actual end date (October 2011) added as reported by ClinicalTrials.gov.
- 07 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.